Skip to main content

Peer Review reports

From: Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system

Original Submission
3 Feb 2024 Submitted Original manuscript
2 Mar 2024 Reviewed Reviewer Report - Gaurav Chikara
26 Mar 2024 Reviewed Reviewer Report
3 Apr 2024 Author responded Author comments - Wei Zhuang
Resubmission - Version 2
3 Apr 2024 Submitted Manuscript version 2
12 Apr 2024 Reviewed Reviewer Report
21 Apr 2024 Reviewed Reviewer Report - Gaurav Chikara
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
22 Apr 2024 Editorially accepted
9 May 2024 Article published 10.1186/s12879-024-09339-4

You can find further information about peer review here.

Back to article page